Diagnosed with Cancer? Your two greatest challenges are understanding cancer and understanding possible side effects from chemo and radiation. Knowledge is Power!
Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
Intravenous Vitamin C Therapy and Cancer
Intravenous Vitamin C Therapy and Cancer: What the Research Shows. Evidence-based non-conventional therapies for cancer patients and survivors…
Many cancer patients search for therapies that may improve treatment outcomes, reduce side effects, and support overall health during and after conventional therapy. One integrative approach receiving increasing scientific attention is high-dose intravenous vitamin C (IVC) therapy.
While vitamin C supplements taken by mouth cannot reach the blood concentrations needed for anti-tumor activity, intravenous delivery allows extremely high plasma levels that appear to behave differently in the body. This pharmacologic dosing has been studied for decades and continues to be explored in modern clinical trials.
I am a long-term MM survivor. I blog about cancer daily. The most popular blog post on PeopleBeatingCancer.org is “Myeloma Diet.”
I wrote that post years ago, long before I had even learned about the benefits of intravenous vitamin C therapy. While I think nutrition is important for MM patients, I believe that preparing for cancer therapies with
is equally, if not more, important.
Email me at David.PeopleBeatingCancer@gmail.com to learn more about managing your MM with both conventional and non-conventional therapies.
Good luck,
David Emerson
Below is an overview of what current research says about intravenous vitamin C and cancer.
Can High-Dose Vitamin C Fight Cancer? | The Science Behind IV Vitamin C Therapy
Why Intravenous Vitamin C Is Different
When vitamin C is taken orally, absorption is tightly controlled by the digestive system. Blood levels remain relatively low.
In contrast, intravenous vitamin C bypasses the gut, allowing plasma concentrations many times higher than oral dosing can achieve. These high concentrations may have anti-cancer properties that oral vitamin C does not produce.
Research shows that pharmacologic concentrations of vitamin C can only be achieved through IV infusion, and these levels can be toxic to certain cancer cells while leaving normal cells largely unaffected.
Potential Anti-Cancer Mechanisms of IV Vitamin C
1. Selective Oxidative Stress in Cancer Cells
High-dose vitamin C can act as a pro-oxidant rather than an antioxidant at pharmacologic levels.
This process generates hydrogen peroxide in tissues, which cancer cells are often less able to detoxify. The resulting oxidative stress can damage tumor cells while sparing normal cells.
Modern molecular studies show that high-dose vitamin C may:
- Generate hydrogen peroxide toxic to tumor cells
- Disrupt tumor metabolism
- Regulate cancer-related epigenetic pathways
- Inhibit oncogenic signaling pathways
- Enhance immune responses against tumors
2. Improved Effectiveness of Chemotherapy and Radiation
Several studies suggest that intravenous vitamin C may enhance the effectiveness of conventional cancer therapies.
For example:
- Laboratory and clinical research indicates that vitamin C may increase the effectiveness of chemotherapy agents.
- High-dose ascorbate has been shown to increase radiosensitivity of glioblastoma cells, leading to greater tumor cell death when combined with radiation therapy.
Because of these findings, many current trials evaluate IV vitamin C as an adjunct therapy, rather than a replacement for standard treatment.
3. Possible Survival Benefits in Some Cancers
Early clinical trials are beginning to investigate whether adding IV vitamin C to standard cancer treatment may improve survival outcomes.
One randomized phase II study in metastatic pancreatic cancer found that adding high-dose intravenous vitamin C to chemotherapy doubled median survival compared with chemotherapy alone.
Other ongoing trials are evaluating vitamin C infusions for cancers such as:
- Pancreatic cancer
- Colorectal cancer
- Lung cancer
- Solid tumors with KRAS or BRAF mutations
Although these findings are promising, larger phase III trials are still needed.
4. Improved Quality of Life for Cancer Patients
One of the most consistent findings in research on IV vitamin C is improved quality of life during cancer treatment.
Studies and reviews report that intravenous vitamin C may help reduce symptoms such as:
- Fatigue
- Nausea
- Pain
- Insomnia
- Depression
- Chemotherapy toxicity
These benefits may make treatment more tolerable for some patients.
5. Safety Profile
Research suggests that intravenous vitamin C is generally well tolerated when administered by trained clinicians.
Clinical trials have found:
- Good safety when combined with chemotherapy
- Minimal severe side effects in most patients
However, IV vitamin C may not be appropriate for everyone. Patients with kidney disease or G6PD deficiency require special screening before treatment.
Important Limitations of Current Research
Despite encouraging data, researchers emphasize that IV vitamin C is still being investigated.
Key limitations include:
- Many studies are small or early-phase
- Results vary across cancer types
- Large randomized trials are still limited
Systematic reviews conclude that the evidence is suggestive but not yet definitive, and more rigorous research is needed.
Bottom Line
Current research suggests that intravenous vitamin C may offer several potential benefits for cancer patients, including:
- Selective toxicity toward cancer cells
- Enhanced effectiveness of chemotherapy or radiation
- Improved quality of life during treatment
- Possible survival benefits in some cancers
However, it is best viewed as a complementary therapy rather than a stand-alone cancer treatment.
Patients considering IV vitamin C should discuss it with an oncologist or integrative oncology specialist to ensure safety and coordination with their overall treatment plan.
Research References
- High-dose intravenous vitamin C as an anti-cancer agent
https://pubmed.ncbi.nlm.nih.gov/34717701/ - Intravenous vitamin C and cancer: systematic review
https://www.ncbi.nlm.nih.gov/books/NBK242607/ - Randomized trial of pharmacological ascorbate with chemotherapy
https://pubmed.ncbi.nlm.nih.gov/39369582/ - Intravenous vitamin C combined with cytotoxic chemotherapy
https://pubmed.ncbi.nlm.nih.gov/25848948/ - Intravenous vitamin C (PDQ) – National Cancer Institute
https://www.cancer.gov/about-cancer/treatment/cam/hp/vitamin-c-pdq - Systematic review of intravenous ascorbate in cancer therapy
https://pmc.ncbi.nlm.nih.gov/articles/PMC6071214/ - Intravenous Vitamin C Therapy and Cancer: What the Research Shows Intravenous Vitamin C Therapy and Cancer: What the Research Shows.
To Learn More About Complementary Therapies